Related Experiment Video
Updated: Jan 21, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Pulmonary Histoplasmosis
1Division of Infectious Diseases, Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105. ckauff@umich.edu
Abstract:
Most patients with pulmonary histoplasmosis experience a self-limited illness that rarely requires treatment. However, patients who inhale a large burden of organisms from the environment and those who are immunosuppressed may develop severe, life-threatening pneumonia. Chronic histoplasmosis occurs almost exclusively in patients with severe chronic obstructive pulmonary disease. Complications of pulmonary histoplasmosis are mostly related to persistent mediastinal lymphadenopathy. Mild to moderate forms of pulmonary histoplasmosis should be treated with itraconazole. Patients with severe pulmonary involvement should initially receive amphotericin B; after the patient's condition has improved, therapy can be changed to itraconazole. Preventive measures should be used to protect workers from exposure to large numbers of Histoplasma capsulatum organisms.
Insights
Pulmonary histoplasmosis is usually mild but can be severe in immunocompromised individuals or those with COPD. Treatment depends on severity, ranging from itraconazole to amphotericin B.
Area of Science:
- Infectious Diseases
- Pulmonology
- Mycology
Background:
- Pulmonary histoplasmosis is a fungal infection caused by Histoplasma capsulatum.
- Most cases are self-limiting, but severe disease can occur.
Purpose of the Study:
- To review the clinical presentation, complications, and treatment of pulmonary histoplasmosis.
- To emphasize preventive measures for high-risk individuals.
Main Methods:
- Literature review of pulmonary histoplasmosis.
- Analysis of clinical manifestations and treatment outcomes.
Main Results:
- Severe pneumonia can develop in immunocompromised patients or with high organism burden.
- Chronic histoplasmosis is associated with severe COPD.
- Mediastinal lymphadenopathy is a common complication.
Conclusions:
- Mild to moderate cases are treated with itraconazole.
- Severe cases require initial amphotericin B followed by itraconazole.
- Preventive measures are crucial for occupational exposure.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

